Search Results: Cardiovascular (279)

In a momentous stride forward for cardiac healthcare, St. Luke’s Medical Center proudly celebrates the grand opening of its highly anticipated Center for Structural Heart and Vascular Interventions (CSHVI). This cutting-edge facility stands as a towering symbol of innovation, poised to redefine the very landscape of cardiovascular care. With its pioneering approach to minimally invasive treatment options, the CSHVI is set to revolutionise how patients grappling with complex heart and vascular diseases are cared for.

As the world shifts its focus from the immediate threat of the COVID-19 pandemic, another health concern, often silent but equally impactful, is gaining prominence. Non-alcoholic Fatty Liver Disease (NAFLD), recognised as the “silent epidemic,” has emerged as a significant global health issue, affecting an estimated 38% of the world’s population.

In a concerning statistic emerging from Malaysia, almost 100,000 individuals succumbed prematurely to various non-communicable diseases (NCDs) in 2022, falling short of the national average life expectancy of 75 years.  The primary culprits behind these early deaths were heart and cerebrovascular diseases, along with pneumonia, underscoring a pressing health crisis in the country.